Skip to main content

Table 4 Physicians' reports of how they use CHD global risk assessment for primary prevention, among those who use CHD risk assessment (N = 358)

From: Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians

  All Family Physicians General Internists Cardiologists P- value*
  % % % %  
Use global CHD risk estimate to guide lipid lowering therapy recommendations (n = 355) 69.0 63.5 72.4 73.3 0.16
Use global CHD risk estimate to guide aspirin therapy recommendations (n = 350) 53.7 52.4 51.4 56.5 0.72
Use global CHD risk estimate to guide blood pressure lowering therapy recommendations (n = 356) 48.3 48.7 44.7 50.0 0.76
Use global CHD risk estimate to guide any primary prevention therapy recommendation (n = 358) † 76.8 73.2 79.0 79.7 0.38
Tell patients their global CHD risk (n = 352) 40.1 37.7 33.0 49.2 0.01
  1. CHD = coronary heart disease
  2. *Overall p-values based on Pearson's chi squared test for significance between specialty groups
  3. † Based on using risk estimate to guide lipid lowering, aspirin, or blood pressure lowering recommendation